台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP07-02: Therapeutic efficacy of 180-W greenlight xps vaporization of the prostate for the storage symptoms concomitant with benign prostatic obstruction and a search for outcome predictors

2022-06-07 • 觀看: 1232 • 回應: 0 • doc
MP07-01: The therapeutic effects of peptide decoy-loaded hydrogel in mice with bladder outlet obstruction-induced bladder injury

2022-06-07 • 觀看: 1320 • 回應: 0 • doc
MP06-10: Characteristics of mCRPC patients received Abiraterone acetate plus prednisolone and Enzalutamide before chemotherapy

2022-06-07 • 觀看: 1269 • 回應: 0 • doc
MP06-09: KCGMH experience and meta-analysis: 6-cycle complete rate of Radium-223 therapy in Mcrpc patients with different treatment sequences

2022-06-07 • 觀看: 1196 • 回應: 0 • doc
MP06-08: Treatment strategy and systemic review with PSMA PET/CT scan in progressive advanced prostate cancer

2022-06-07 • 觀看: 1551 • 回應: 0 • doc
MP06-07: Oncological and functional outcomes in high risk and very high risk prostate cancer patients receiving robotic-assisted radical prostatectomy

2022-06-07 • 觀看: 1284 • 回應: 0 • doc
MP06-06: The analysis of concordance rates between cancer stage of MR/US fusion prostate biopsy and radical prostatectomy specimen

2022-06-07 • 觀看: 1217 • 回應: 0 • doc
MP06-05: Retzius-sparing robot-assisted radical prostatectomy and extended pelvic lymph node dissection for very high-risk prostate cancer

2022-06-07 • 觀看: 1252 • 回應: 0 • doc
MP06-04: Hyperforin induces extrinsic/intrinsic apoptosis signaling and inhibits NF-кB for metastasis suppression in prostate cancer cells

2022-06-07 • 觀看: 1439 • 回應: 0 • doc
MP06-03: Real world experience of androgen deprivation therapy associated bone fracture risk in newly diagnosed prostate cancer patients

2022-06-07 • 觀看: 1195 • 回應: 0 • doc
MP06-02: A single center experience of Abiraterone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel based chemotherapy

2022-06-07 • 觀看: 1242 • 回應: 0 • doc
MP06-01: Is extraperitoneal extended pelvic lymph node dissection adequate during robotic assisted radical prostatectomy for intermediate and high risk localized prostate cancer?

2022-06-07 • 觀看: 1208 • 回應: 0 • doc

Prev
456
457
458
459
460
461
462
463
464
465
Next
/ 1134